Nomad Foods (NOMD) Stock Forecast & Price Target

Nomad Foods is viewed favorably because it holds leading positions across key European markets, owns strong health-oriented brands such as Birds Eye, Findus, and Iglo, and is benefiting from recovering economic conditions in much of Europe. Despite 1Q26 revenue falling 5.9% and 2Q26 revenue declining 3.1%, gross margin improved to 25.7% and 28.7% respectively, while adjusted EBITDA remained ahead of expectations, signaling resilience even amid volume declines and market share pressure. The positive outlook also rests on new management, tighter marketing and compensation discipline, and greater focus on supply chain and factory consolidation, which together should support free cash flow, capital returns, and a better earnings mix over time.

Nomad Foods is facing a weak fundamental setup because sales are declining, with total sales down 2.2% to 3.4% in the cited periods as volume falls of 2.6% to 4.7% outpace modest price/mix gains, signaling that price increases are not fully offsetting lost demand. Operating performance is also deteriorating, as operating margin slips 60 to 70 bps to 12.6% to 12.7% and adjusted EBITDA falls 8.5% to €478.5MM or 8.6% to €477.7MM, pressured by higher operating expenses and inflation, especially in 4Q. The outlook remains negative because management faces market share losses, retailer resistance to further pricing, and commodity inflation risks, while category growth in Western Europe shows Nomad Foods lagging peers by roughly 700 bps on volume and 750 bps on sales.